Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $71,208 - $80,088
-1,200 Reduced 24.75%
3,649 $230,000
Q4 2020

Feb 19, 2021

SELL
$57.74 - $65.43 $57,740 - $65,430
-1,000 Reduced 17.1%
4,849 $296,000
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $14,763 - $19,257
300 Added 5.41%
5,849 $375,000
Q2 2019

Aug 06, 2019

BUY
$44.62 - $49.34 $8,924 - $9,868
200 Added 3.74%
5,549 $256,000
Q2 2017

Aug 10, 2017

BUY
N/A
5,349
5,349 $298,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Edmonds Duncan Registered Investment Advisors, LLC Portfolio

Follow Edmonds Duncan Registered Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmonds Duncan Registered Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edmonds Duncan Registered Investment Advisors, LLC with notifications on news.